神经药理学报››2017,Vol. 7››Issue (1): 38-44.DOI:10.3969/j.issn.2095-1396.2017.01.005
苏晓梅,张丹参
出版日期:
2017-02-26发布日期:
2017-12-01通讯作者:
张丹参,女,博士生导师;研究方向:神经药理学;Tel:+86-0311-81668016,E-mail:zhangds2011@126.com作者简介:
苏晓梅,女,硕士研究生;研究方向:神经药理学;E-mail:13513210785@163.com基金资助:
国家自然基金项目(No.81274005),河北省自然科学基金项目(No.H2016208058),河北省教育厅科学技术研究重点项目(No.ZD2016009)
SU Xiao-mei,ZHANG Dan-shen
Online:
2017-02-26Published:
2017-12-01Contact:
张丹参,女,博士生导师;研究方向:神经药理学;Tel:+86-0311-81668016,E-mail:zhangds2011@126.comAbout author:
苏晓梅,女,硕士研究生;研究方向:神经药理学;E-mail:13513210785@163.comSupported by:
国家自然基金项目(No.81274005),河北省自然科学基金项目(No.H2016208058),河北省教育厅科学技术研究重点项目(No.ZD2016009)
摘要:人参是我国传统名贵中药材,药用历史悠久。人参中生理活性的最主要成分是人参皂苷,其中人参皂苷-Rg3 是一种药用价值极高的中药成分,研究其药理作用,可以为人参皂苷-Rg3 的进一步开发和利用提供理论指导。该文以近年来国内外关于人参皂苷-Rg3 的文献为基础,对其药理作用进行总结和分析。文献报道的药理研究表明,人参皂苷-Rg3 具有抗肿瘤、降低化疗药物的心脏毒性和肾毒性、翻转肿瘤细胞对抗癌药物的多药耐药性、保护中枢神经系统和心血管系统、抗疲劳、降血糖、修复创面等广泛药理作用。
中图分类号:
苏晓梅,张丹参.人参皂苷-Rg3 的药理作用研究进展[J]. 神经药理学报, 2017, 7(1): 38-44.
SU Xiao-mei,ZHANG Dan-shen.Research Progress in Pharmacological Activities of Ginsenoside-Rg3[J]. Acta Neuropharmacologica, 2017, 7(1): 38-44.
[1] Mar Vergel, Juan J Marin, Purificacion Estevez, et al. Cellular senescence as a target in cancer control[J]. J Aging Res, 2010, 2011(3): 1-13. [2] Seong Sin, Sung Young Kim, Sung Su Kim, et al. Chronic treatment with ginsenoside Rg3 induces Akt-dependent senescence in human glioma cells[J]. Int J Oncol, 2012, 41(5): 1669-1674. [3] Claire Louise Allen, Ulvi Bayraktutan. Oxidative stress and its role in the pathogenesis of ischaemic stroke[J]. Int J Stroke, 2009, 4(6): 461-470. [4] Ding Shi-jie, Li Chun-bao, Cheng Ning-hui, et al. Redox regulation in cancer stem cells[J]. Oxid Med Cell Longev, 2015, 2015: 1-11. [5] Yoon Ji Choi, Hyun Joo Lee, Kang Dong-wan, et al. Ginsenoside Rg3 induces apoptosis in the U87MG human glioblastoma cell line through the MEK signaling pathway and reactive oxygen species[J]. Oncol Rep, 2013, 30(3): 1362-1370. [6] Sajani S Lakka, Jasti S Rao. Antiangiogenic therapy in brain tumors[J]. Expert Rev Neurother, 2008, 8(10): 1457-1473. [7] Sun Cai-xing, Yu Yang, Wang Li-zhen, et al. Additive antiangiogenesis effect of ginsenoside Rg3 with low-dose metronomic temozolomide on ratglioma cells both in vivo and in vitro[J]. J Exp Clin Cancer Res, 2016, 35(1): 32-44. [8] Eun Ji Joo, Jaemoo Chun, Young Wan Ha, et al. Novel roles of ginsenoside Rg3 in apoptosis through downregulation of epidermal growth factor receptor[J]. Chem Biol Interact, 2015, 233: 25-34. [9] Xie Qi-peng, Wen Huai-kai, Zhang Qiong, et al. Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell[J]. Biomed Pharmacother, 2017, 85: 16-21. [10] Hwa Yeon Sun, Jun Hee Lee, Yong-seok Han, et al. Pivotal roles of ginsenoside Rg3 in tumor apoptosis through regulation of reactive oxygen species[J]. Anticancer Res, 2016, 36(9): 4647-4654. [11] Liu Tai-guo, Huang Ying, Cui Dan-dan, et al. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice[J]. BMC Cancer, 2009, 9(1): 250-261. [12] Dong-Gun Kim, Kyung Hee Jung, Da-Gyum Lee, et al. 20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin[J]. Oncotarget, 2014, 5(12): 4438-4451. [13] Zhou Bo, Wang Jian-hua, Yan Zhi-ping. Ginsenoside Rg3 attenuates hepatoma VEGF overexpression after hepatic artery embolization in an orthotopic transplantation hepatocellular carcinoma rat model[J]. Onco Target Ther, 2014, 7: 1945-1954. [14] Zhang Yun, Liu Qing-zhan, Xing Su-ping, et al. Inhibiting effect of Endostar combined with ginsenoside Rg3 on breast cancer tumor growth in tumor-bearing mice[J]. Asian Pac J Trop Med, 2016, 9(2): 180-183. [15] Bo-Mim Kim, Do-Hee Kim, Jeong-Hill Park, et al. Ginsenoside Rg3 inhibits constitutive activation of NF-κB signaling in human breast cancer (MDA-MB-231) cells: ERK and Akt as potential upstream targets[J]. J Cancer Prev, 2014, 19(1): 23-30. [16] 彭梦娇, 翟惠, 冯艳华, 等. Rg3通过PI3K/Akt调控MGBA表达促进乳腺癌细胞凋亡的研究[J]. 辽宁医学院学报, 2016, 37(3): 1-11. [17] Xu Tian-min, Cui Man, Xin Y, et al. Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis[J]. Chin Med J, 2008, 121(15): 1394-1397. [18] 王东辉, 闻春艳. 人参皂苷-Rg3对宫颈癌荷瘤小鼠治疗作用的实验研[J]. 中国妇幼保健, 2016, 31(19): 4046-4048. [19] Seung Jae Lee, Woo Jin Lee, Sung Eun Chang, et al. Antimelanogenic effect of ginsenoside Rg3 through extracellular signal-regulated kinase-mediated inhibition of micro-phthalmia associated transcription factor[J]. J Ginseng Res, 2015, 39(3):238-242. [20] Shan Xiu, Tian Li-li, Zhang Yu-mei, et al. Ginsenoside Rg3 suppresses FUT4 expression through inhibiting NF-κB/p65 signaling pathway to promote melanoma cell death[J]. Int J Oncol, 2015, 47(2): 701-709. [21] Zhang Fei, Li Mao-lan, Wu Xiang-song, et al. 20(S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway[J]. Drug Des Devel Ther, 2015, 9: 3969-3687. [22] Chang Liang, Huo Bing, Lv Ya-lei, et al. Ginsenoside Rg3 enhances the inhibitory effects of chemotherapy on esophageal squamous cell carcinoma in mice[J]. Mol Clin Oncol, 2014, 2(6): 1043-1046. [23] 张继华, 陈春菊, 宋冬梅, 等. 人参皂甙Rg3对人喉鳞癌裸鼠移植瘤中SIX1、TGF-β、VEGF-C表达的影响[J]. 中药药理与临床, 2016, 32(2): 91-94. [24] Wang Xiao-ying, Chen Li-li, Wang Ting, et al. Ginsenoside Rg3 antagonizes adriamycin-induced cardiotoxicity by improving endothelial dysfunction from oxidative stress via upregulating the Nrf2-ARE pathway through the activation of akt[J]. Phytomedicine, 2015, 22(10): 875-884. [25] Myoung-Sik Han MS, Im-Ho Han, Dahae Lee, et al. Beneficial effects of fermented black ginseng and its ginsenoside 20(S)-Rg3 against cisplatin-induced nephrotoxicity in LLC-PK1 cells[J]. J Ginseng Res, 2016, 40(2): 135-140. [26] Young Ju Lee, Sangchul Lee, Jin Nyoung Ho, et al. Synergistic antitumor effect of ginsenoside Rg3 and cisplatin in cisplatin resistant bladder tumor cell line[J]. Oncol Rep, 2014, 32(5): 1803-1808. [27] Sung Su Kim, Sin Seong, Sung Young Kim. Synergistic effect of ginsenoside Rg3 with verapamil on the modulation of multidrug resistance in human acute myeloid leukemia cells[J]. Oncol Lett, 2014, 7(4): 1265-1269. [28] He Bo, Chen Peng, Yang Jian-yu, et al. Neuroprotective effect of 20(R)-ginsenoside Rg(3) against transient focal cerebral ischemia in rats[J]. Neurosci Lett, 2012, 526(2): 106-111. [29] 何波, 陈鹏, 龙江, 等. 20(R)-人参皂苷-Rg3对大鼠缺血再灌注后迟发性神经元损伤的保护作用[J]. 时珍国医国药, 2016, 27(1): 35-38. [30] Tian Jing-wei, Fu Feng-hua, Geng Mei-yu, et al. Neuroprotective effect of 20(S)-ginsenoside Rg3 on cerebral ischemia in rats[J]. Neurosci Lett, 2005, 374(2): 92-97. [31] Tian Jing-wei, Zhang Shu-min, Li Gui-sheng, et al. 20(S)-ginsenoside Rg3, a neuroprotective agent, inhibits mitochondrial permeability transition pores in rat brain[J]. Phytother Res, 2009, 23(4): 486-491. [32] 陈群伟, 舒琦瑾, 刘清君, 等. 人参皂苷-Rg3对大鼠奥沙利铂神经毒性的保护作用[C]. 重庆: 青年中西医结合肿瘤学术论坛, 2015: 118-127. [33] Bao Hai-ying, Zhang Jing, Yeo Soo-Jeong, et al. Memory enhancing and neuroprotective effects of selected ginsenosides[J]. Arch Pharm Res, 2005, 28(3): 335-342. [34] You Zheng-chen, Yao Qi, Shen Jian-hong, et al. Antidepressant-like effects of ginsenoside Rg3 in mice via activation of the hippocampal BDNF signaling cascade[J]. J Nat Med, 2017, 71(2): 367-379. [35] Zhang Hua-lin, Zhou Zhong-liu, Chen Zi-ming, et al. Ginsenoside Rg3 exerts anti-depressive effect on an NMDA-treated cell model and a chronic mild stress animal model[J]. J Pharmacol Sci, 2017, 134(1): 45-54. [36] Kyung Hee Lee, In Young Bae, Song I Park, et al. Antihypertensive effect of Korean Red Ginseng by enrichment of ginsenoside Rg3 and arginine-fructose[J]. J Ginseng Res, 2016, 40(3): 237-244. [37] Cho Y S, Kim C H, Kim H N, et al. Ginsenoside Rg3 inhibits lipopolysaccharide-induced adhesion molecule expression in human umbilical vein endothelial cell and C57BL/6 mice[J]. Pharmazie, 2014, 69(11): 818-822. [38] Nu Yu-xia, Zhang Peng, Wang Chu, et al. Effect of ginsenoside Rg3 on tyrosine hydroxylase and related mechanisms in the forced swimming-induced fatigue rats[J]. J Ethnopharmacol, 2013, 150(1): 138-147. [39] Tang Wen-yan, Zhang Yi, Gao Jing, et al. The anti-fatigue effect of 20(R)-ginsenoside Rg3 in mice by intranasally administratio[J]. Biol Pharm Bull, 2008, 31(11): 2024-2027. [40] Zhang Wen-jing, Zhang Yue, Ma Xian-de, et al. Effects of acupuncturing Pishu combined with Ginsenoside Rg3 on the immune function of rats with chronic fatigue[J]. Int J Clin Exp Med, 2015, 8(10): 19022-19029. [41] Chen Fang, Chen Yue-wen, Kang Xin-cong, et al. Antiapoptotic function and mechanism of ginseng saponins in rattus pancreatic β-cells[J]. Biol Pharm Bull, 2012, 35(9): 1568-1573. [42] Soo Lim, Ji Won Yoom, Sung Hee Choi, et al. Effect of ginsam, a vinegar extract from Panax ginseng, on body weight and glucose homeostasis in an obese insulin-resistant rat model[J]. Metabolism, 2009, 58(1): 8-15. [43] Min Joo Kim, Young Do Koo, Min Kim, et al. Rg3 improves mitochondrial function and the expression of key genes involved in mitochondrial biogenesis in C2C12 myotubes[J]. Diabetes Metab J, 2016, 40(5): 406-413. [44] Johan Waden, Carol Forsblom, Lena M Thorn, et al. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes[J]. Diabetes, 2009, 58(11): 2649-2655. [45] You Jeong Kim, Su Min Park, Hye Sook Jung, et al. Ginsenoside Rg3 prevents INS-1 cell death from intermittent high glucose stress[J]. Islets, 2016, 8(3): 57-64. [46] Cheng Zhi-qiang, Li Li. Ginsenoside Rg3 ameliorates lipopolysaccharide-induced acute lung injury in mice through inactivating the nuclear factor-κB (NF-κB) signaling pathway[J]. Int Immunopharmacol, 2016, 34: 53-59. [47] Wang J, Yu X F, Zhao J J, et al. Ginsenoside Rg3 attenuated omethoate-induced lung injury in rats[J]. Hum Exp Toxicol, 2016, 35(6): 677-684. [48] Fei Hong-qiang, Li Meng-xuan, Liu Wen-jun, et al. Potential lipase inhibitors from Chinese medicinal herbs[J]. Pharm Biol, 2016, 54(12): 2845-2850. [49] 李静平, 郑永仁, 张燕. 人参皂苷-Rg3对糖尿病大鼠创面修复作用的实验研究[J]. 云南中医中药杂志, 2016, 37(1): 25-28. [50] 马莉, 李晓静. 人参皂苷-Rg3对兔耳增生性瘢痕TNF-α和IL-β表达的影[J]. 云南中医学院学报, 2016, 39(1): 6-9. |
[1] | 许家其, 张海红.广藿香作用的研究进展[J]. 神经药理学报, 2020, 10(3): 27-32. |
[2] | 孙逸, 侯雪芹, 王福刚.当归芍药散改善认知功能的研究进展[J]. 神经药理学报, 2020, 10(3): 42-46. |
[3] | 张健美, 张丹参.马勃的化学成分及其药理作用的研究进展[J]. 神经药理学报, 2020, 10(2): 11-14. |
[4] | 刘杉, 李炜.L- 茶氨酸药理作用的研究进展[J]. 神经药理学报, 2020, 10(2): 24-32. |
[5] | 宋宜蕾,侯雪芹,郝吉福.蛇床子现代药理学作用及临床应用的研究进展[J]. 神经药理学报, 2019, 9(6): 58-63. |
[6] | 杨靖,苑文英.弓形虫感染对神经组织损伤及通过血脑屏障机制[J]. 神经药理学报, 2019, 9(5): 40-43. |
[7] | 吴县,洪浩.胆汁酸及其受体与中枢神经系统疾病[J]. 神经药理学报, 2019, 9(1): 23-30. |
[8] | 李双双, 郭春燕.桃红四物汤化学成分及药理作用研究进展[J]. 神经药理学报, 2016, 6(4): 42-49. |
[9] | 张涛, 张斌, 王佩义, 周涛, 秦雪梅.定坤丹组方药物化学成分与药理作用研究进展[J]. 神经药理学报, 2015, 5(6): 40-50. |
[10] | 汪伦政,谢文娟,唐铁山.神经干细胞、成体神经发生以及神经变性疾病的细胞移植治疗[J]. 神经药理学报, 2015, 5(3): 46-64. |
[11] | 唐闻晶, 马登磊, 李林.体视学在神经欧宝娱乐-意甲尤文图斯亚洲区域合作伙伴 领域中的应用[J]. 神经药理学报, 2014, 4(5): 24-29. |
[12] | 梅艳飞, 张丹参.丹参酮ⅡA的药理作用及治疗应用研究进展[J]. 神经药理学报, 2014, 4(5): 55-64. |
[13] | 李国风, 骆海坤, 张建新.硫化氢在中枢神经系统疾病中的作用研究进展[J]. 神经药理学报, 2014, 4(3): 49-56. |
[14] | 郭兴道 李炜 张癸荣 张丹参 程鹏.睡眠剥夺对学习记忆及中枢神经系统相关分子的影响[J]. 神经药理学报, 2014, 4(1): 34-51. |
[15] | 李英杰,杨宝学.吸入麻醉药对组织器官缺血再灌注损伤的保护作用[J]. 神经药理学报, 2013, 3(1): 28-36. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||